Increased herpes zoster risk found for those with versus without COVID-19, with more pronounced risk following COVID-19 hospitalization
Fourth Dose of BNT162b2 Offers Protection Against Severe COVID-19
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose; protection against infection waned
COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 4 to 8, 2022. This …
Vaccination Mandate for Federal Workers Reinstated by Appeals Court
Mandate was introduced in September but enforcement was halted in January by a preliminary injunction issued by a federal judge in Texas